Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.

J Autoimmun · 2017 · PMC5656106 · PMID 28663002

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

bordered on significancep = 0.055so close (0.05 < p ≤ 0.1)

In this larger cohort the association between anti-NXP2 and the development of calcinosis bordered on significance (OR 1.82 (0.99–3.36), p = 0.055). 3.4.3 Anti-melanoma differentiation associated protein 5 (Anti-MDA5, anti-CADM 140) Anti-MDA5 is the third most common autoantibody in the myositis cohort and was identified in 6% of patients.

also in 114 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.